Security
RXRX · RECURSION PHARMACEUTICALS, INC.
RXRXNASDAQCommon stockCurrentCIK 1601830Updated Sep 26, 2026
Name history
Recursion Pharmaceuticals, LLC · through Dec 4, 2015
RXRX price & chart
Loading TradingView…
NASDAQ:RXRX on TradingView ↗In the news
Recursion to Participate in Upcoming Investor Conferences ↗
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed ↗
Recent filings
Entry into a Material Definitive Agreement
Items 1.01
144 filing
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,474,130,000Source | 1,448,598,000Source | 653,699,000Source | 701,288,000Source |
| Property, Plant and Equipment, NetUSD | 103,931,000Source | 141,063,000Source | 86,510,000Source | 88,192,000Source |
| GoodwillUSD | 162,158,000Source | 148,873,000Source | 52,056,000Source | 801,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 309,903,000Source | 335,855,000Source | 36,443,000Source | 1,306,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 743,294,000Source | 594,350,000Source | 391,565,000Source | 549,912,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | — | 0Source |
| Assets, CurrentUSD | 812,845,000Source | 714,269,000Source | 438,137,000Source | 569,814,000Source |
| Operating Lease, Right-of-Use AssetUSD | 45,339,000Source | 65,877,000Source | 33,663,000Source | 33,255,000Source |
| Other Assets, NoncurrentUSD | 12,754,000Source | 8,825,000Source | 261,000Source | 0Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 343,265,000Source | 413,816,000Source | 190,263,000Source | 215,482,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 5,000Source | 4,000Source | 2,000Source | 2,000Source |
| Additional Paid in CapitalUSD | 3,170,145,000Source | 2,473,698,000Source | 1,431,056,000Source | 1,125,360,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,076,002,000Source | -1,431,283,000Source | -967,622,000Source | -639,556,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 36,717,000Source | -7,637,000Source | — | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 1,130,865,000Source | 1,034,782,000Source | 463,436,000Source | 485,806,000Source |
| Liabilities and EquityUSD | 1,474,130,000Source | 1,448,598,000Source | 653,699,000Source | 701,288,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 147,707,000Source | 187,472,000Source | 93,171,000Source | 100,265,000Source |
| Operating Lease, Liability, CurrentUSD | 12,663,000Source | 13,795,000Source | 6,116,000Source | 5,952,000Source |
| Accounts Payable, CurrentUSD | 18,118,000Source | 21,613,000Source | 3,953,000Source | 4,586,000Source |
| Operating Lease, Liability, NoncurrentUSD | 46,647,000Source | 67,250,000Source | 43,414,000Source | 44,420,000Source |
| Deferred Income Tax Liabilities, NetUSD | 23,255,000Source | 16,575,000Source | 1,339,000Source | — |
| Other Liabilities, NoncurrentUSD | 2,080,000Source | 4,732,000Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 70,230,000Source | 81,872,000Source | 46,635,000Source | 32,904,000Source |
| Deferred Tax Liabilities, NetUSD | 23,255,000Source | 16,466,000Source | 1,339,000Source | — |
| Short-term InvestmentsUSD | — | — | — | 0Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 83,701,000Source | 36,494,000Source | 24,402,000Source | 11,756,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 111,223,000Source | 81,688,000Source | 53,503,000Source | 27,909,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -2,616,000Source | 6,435,000Source | -987,000Source | 1,767,000Source |
| Deferred Income Tax Expense (Benefit)USD | -368,000Source | -1,630,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -371,808,000Source | -359,174,000Source | -287,780,000Source | -83,524,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | -277,104,000Source | -1,844,000Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -16,871,000Source | 260,059,000Source | -10,228,000Source | 193,249,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 6,469,000Source | 13,695,000Source | 11,955,000Source | 37,059,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 521,532,000Source | 304,120,000Source | 140,133,000Source | 154,345,000Source |
| Repayments of Long-term DebtUSD | — | — | 766,000Source | 90,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 150,897,000Source | 201,599,000Source | -157,687,000Source | 263,763,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 753,921,000Source | 603,024,000Source | 401,425,000Source | 559,112,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | 96,000Source | 55,000Source |
| Income Taxes Paid, NetUSD | 237,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 18,044,000Source | -3,406,000Source | 188,000Source | -307,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 110,018,000Source | 79,501,000Source | 51,679,000Source | 26,872,000Source |
| Amortization of Intangible AssetsUSD | 50,300,000Source | 18,800,000Source | 8,500,000Source | 379,000Source |
| DepreciationUSD | 33,700,000Source | 18,300,000Source | 15,900,000Source | 11,400,000Source |
| Gain (Loss) on Disposition of BusinessUSD | -4,502,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source |
| General and Administrative ExpenseUSD | 176,589,000Source | 178,184,000Source | 110,822,000Source | 81,599,000Source |
| GoodwillUSD | 162,158,000Source | 148,873,000Source | 52,056,000Source | 801,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | -136,000Source | -1,127,000Source | -4,062,000Source | 0Source |
| InterestExpenseNonoperatingUSD | 1,810,000Source | 1,572,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -644,759,000Source | -463,661,000Source | -328,066,000Source | -239,476,000Source |
| Nonoperating Income (Expense)USD | 3,237,000Source | 14,216,000Source | 17,932,000Source | 6,251,000Source |
| Operating Lease, ExpenseUSD | 22,249,000Source | 16,616,000Source | 8,063,000Source | 7,730,000Source |
| Payments to Acquire InvestmentsUSD | 3,806,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | 528,864,000Source | 300,417,000Source | 128,093,000Source | 143,711,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 74,681,000Source | 58,839,000Source | 44,575,000Source | 39,843,000Source |
| Cost of RevenueUSD | 70,953,000Source | 45,238,000Source | 42,587,000Source | 48,275,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | -648,132,000Source | -479,004,000Source | -350,060,000Source | -245,727,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -644,895,000Source | -464,788,000Source | -332,128,000Source | — |
| Income Tax Expense (Benefit)USD | -136,000Source | -1,127,000Source | -4,062,000Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -644,759,000Source | -463,661,000Source | -328,066,000Source | -239,476,000Source |
| Earnings Per Share, BasicUSD per share | -1.44Source | -1.69Source | -1.58Source | -1.36Source |
| Earnings Per Share, DilutedUSD per share | -1.44Source | -1.69Source | -1.58Source | -1.36Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 447,446,109Source | 274,207,146Source | 207,853,702Source | 175,537,487Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 447,446,109Source | 274,207,146Source | 207,853,702Source | 175,537,487Source |
| Interest Expense (non-operating)USD | 1,810,000Source | 1,572,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 50,300,000Source | 18,800,000Source | 8,500,000Source | 379,000Source |
| Costs and ExpensesUSD | 722,813,000Source | 537,843,000Source | 394,635,000Source | 285,570,000Source |
| Current Income Tax Expense (Benefit)USD | 232,000Source | 504,000Source | — | — |
| General and Administrative ExpenseUSD | 176,589,000Source | 178,184,000Source | 110,822,000Source | 81,599,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -537,644,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 97,000Source | 55,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 20,978,000Source | 14,186,000Source | — | — |
| Interest Revenue (Expense), NetUSD | — | — | 19,019,000Source | 6,199,000Source |
| Nonoperating Income (Expense)USD | 3,237,000Source | 14,216,000Source | 17,932,000Source | 6,251,000Source |
| Operating Lease, ExpenseUSD | 22,249,000Source | 16,616,000Source | 8,063,000Source | 7,730,000Source |
| Research and Development ExpenseUSD | 475,271,000Source | 314,421,000Source | 241,226,000Source | 155,696,000Source |